Gene forum 2022 conference encourages researchers and practitioners to submit original contributions.
// SCIENTIFIC SESSION
Global and regional case studies
Gene therapy raw materials customization
Efficient human genome editing
Vector systems and manufacturing
Building a global clinical trial for rare disease patients
Frame work and ethical practice for gene therapy in healthcare system
Navigating gene therapy safety in clinical development
Manufacturing and commercializing gene therapies in australia
Selection & management of suppliers and contract service provider
Developing translational strategy to set up for preclinical & clinical programs
Implication of gene therapy in health practice after clinical trial
Next-generation sequencing workflow In future evolution of gene therapy development
Abstract Submission Guidelines
Overview of abstract submission and evaluation process:
Abstracts submitted to the conference should be written in English only.
Abstracts should be submitted as per the template available above.
Authors can submit their abstracts in Doc, Docx and Pdf format.
Any act of plagiarism is totally unacceptable.
Each abstract should be strictly within 1 page in length, contains about 500 words.
The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
The type of presentation should be nominated while submitting the abstract.
The abstract submission should be made via conference website only.
Submissions not meeting these guidelines risk rejection without consideration of their merits.
Notification of acceptance or rejection of the scientific committee will be given after a week of submission.
All accepted abstracts will be published in the conference proceedings and the proceedings book will be distributed to all the conference attendees at the registration desk on the day of the conference.